KR102542329B1 - 항염 또는 항혈관신생용 약제학적 조성물 - Google Patents

항염 또는 항혈관신생용 약제학적 조성물 Download PDF

Info

Publication number
KR102542329B1
KR102542329B1 KR1020200178410A KR20200178410A KR102542329B1 KR 102542329 B1 KR102542329 B1 KR 102542329B1 KR 1020200178410 A KR1020200178410 A KR 1020200178410A KR 20200178410 A KR20200178410 A KR 20200178410A KR 102542329 B1 KR102542329 B1 KR 102542329B1
Authority
KR
South Korea
Prior art keywords
hyaluronic acid
sulfated
pharmaceutical composition
sulfated hyaluronic
group
Prior art date
Application number
KR1020200178410A
Other languages
English (en)
Korean (ko)
Other versions
KR20210081269A (ko
Inventor
양정아
서혜원
소진언
Original Assignee
주식회사 엘지화학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엘지화학 filed Critical 주식회사 엘지화학
Publication of KR20210081269A publication Critical patent/KR20210081269A/ko
Application granted granted Critical
Publication of KR102542329B1 publication Critical patent/KR102542329B1/ko

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020200178410A 2019-12-23 2020-12-18 항염 또는 항혈관신생용 약제학적 조성물 KR102542329B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20190173213 2019-12-23
KR1020190173213 2019-12-23

Publications (2)

Publication Number Publication Date
KR20210081269A KR20210081269A (ko) 2021-07-01
KR102542329B1 true KR102542329B1 (ko) 2023-06-13

Family

ID=76575613

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020200178410A KR102542329B1 (ko) 2019-12-23 2020-12-18 항염 또는 항혈관신생용 약제학적 조성물

Country Status (3)

Country Link
KR (1) KR102542329B1 (zh)
TW (1) TWI809338B (zh)
WO (1) WO2021133000A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116640315B (zh) * 2023-05-31 2024-07-19 江南大学 一种硫酸化透明质酸-支链聚乙烯亚胺接枝聚合物及其衍生物和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120101059A1 (en) * 2009-05-14 2012-04-26 Fidia Farmaceutici S.P.A. Sulphated hyaluronic acids as regulator agents of the cytokine activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10053053A1 (de) * 2000-10-19 2002-05-16 Knoell Hans Forschung Ev Pharmazeutische Formulierungen zur Hemmung von entzündlichen Arthritiden
ITPD20060219A1 (it) * 2006-05-31 2007-12-01 Fidia Farmaceutici Composizioni farmaceutiche contenenti acido ialuronico solfatato nel trattamento dell'osteoartrosi
IT1397246B1 (it) * 2009-05-14 2013-01-04 Fidia Farmaceutici Nuovi medicamenti ad uso topico a base di acido ialuronico solfatato come agente attivante o inibente l'attivita' citochinica
JP6062917B2 (ja) * 2011-03-23 2017-01-18 ザ ユニバーシティ オブ ユタ リサーチ ファウンデイション 泌尿器科の炎症の治療及び予防の方法
KR20170120991A (ko) * 2016-04-22 2017-11-01 순천향대학교 산학협력단 황화된 히알루론산을 포함하는 의료용 생체 소재
KR102025319B1 (ko) * 2018-11-13 2019-09-25 고려대학교 산학협력단 황산화된 히알루론산 유도체, 이의 제조방법 및 이를 포함하는 근골격계 관절질환의 예방 또는 치료용 약학 조성물

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120101059A1 (en) * 2009-05-14 2012-04-26 Fidia Farmaceutici S.P.A. Sulphated hyaluronic acids as regulator agents of the cytokine activity

Also Published As

Publication number Publication date
TWI809338B (zh) 2023-07-21
KR20210081269A (ko) 2021-07-01
WO2021133000A1 (ko) 2021-07-01
TW202135834A (zh) 2021-10-01

Similar Documents

Publication Publication Date Title
JP3640259B2 (ja) イズロン酸を高含有量有する多糖類
CA2397964A1 (en) Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
US9480702B2 (en) Use of chemically modified heparin derivates in sickle cell disease
KR100855331B1 (ko) 혈관형성 억제 활성을 가지며 응고억제 효과는 없는,헤파라나제 억제제로서 부분적으로 탈황산화된글리코스아미노글리칸의 유도체
RU2014129816A (ru) Неантикоагулянтные гликозаминогликаны, содержащие повторяющиеся дисахаридные звенья, и их медицинское применение
KR102542329B1 (ko) 항염 또는 항혈관신생용 약제학적 조성물
EP1274446B1 (en) Polysaccharidic esters of n-derivatives of glutamic acid
KR20210040359A (ko) 섬유성 유착 치료를 위한 고황산화 푸칸
JP4267916B2 (ja) 多糖体ｋ５から誘導された高度のアンチトロンビン活性を有するグリコサミノグリカン及びその製法
KR102688006B1 (ko) 염증 상태의 치료에서의 작용화된 히알루론산 또는 이의 유도체
US8227449B2 (en) Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
CN110769858A (zh) 水溶性多糖衍生物、其制备工艺及其用途
KR102248721B1 (ko) 황산화 히알루론산 기반의 하이드로겔 및 이를 포함하는 약제학적 조성물
KR20150111554A (ko) 황산콘드로이친을 함유한 유착방지용 조성물과 이의 제조방법

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right